Virus-mediated gene transfer for cutaneous gene therapy.

Area of Science:

• Dermatology
• Gene Therapy
• Molecular Biology

Background:

• The skin acts as a barrier, limiting traditional gene therapy delivery methods.
• Cutaneous gene therapy presents unique challenges and opportunities for viral vector applications.

Purpose of the Study:

• To explore the potential and limitations of viral vectors for gene transfer in the skin.
• To evaluate the feasibility of using keratinocyte stem cells for cutaneous gene therapy.

Main Methods:

• Investigating the susceptibility of skin's keratinocyte stem cells to in vivo retroviral vector transduction.
• Assessing the persistence and transgene expression of cultured, transduced keratinocyte stem cells grafted onto immunocompromised mice.

Main Results:

• Skin's physical barrier and vascular structure pose delivery challenges.
• Keratinocyte stem cells are amenable to direct in vivo and in vitro gene transfer.
• Transduced keratinocyte stem cells demonstrate persistence and expression after grafting.

Conclusions:

• Virus-mediated gene transfer is a primary strategy for cutaneous gene therapy.
• Keratinocyte stem cell manipulation offers a viable route for skin gene therapy.
• Further research into viral vectors is crucial for advancing skin-targeted therapies.